Inventory Used for Balloon-Occluded Retrograde (BRTO) and Antegrade (BATO) Transvenous Obliteration: Sclerosants and Balloon Occlusion Devices

Techniques in Vascular and Interventional Radiology

Volumn 15, Issue 3, 2012, Pages 226-240

  Saad, Wael E A ^a   Nicholson, David ^a   Koizumi, Jun ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Balloon occlusion catheter; BRTO; Gastric; Sclerosant; Transvenous obliteration; Varices

Indexed keywords

ALCOHOL; CARBON DIOXIDE; ENBUCRILATE; GLUCOSE; IODINATED POPPYSEED OIL; POLIDOCANOL; SCLEROSING AGENT;

AIR; ARTICLE; BALLOON ANTEGRADE TRANSVENOUS OBLITERATION; BALLOON CATHETER; BALLOON OCCLUDED RETROGRADE OBLITERATION; BALLOON OCCLUSION; COIL EMBOLIZATION; COMPUTER; COMPUTER ASSISTED TOMOGRAPHY; FOAM; GUIDE WIRE; RADIOGRAPHY;

BALLOON OCCLUSION; CATHETERS; CONTRAST MEDIA; EQUIPMENT DESIGN; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; RADIOGRAPHY, INTERVENTIONAL; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 84866866960     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2012.07.005     Document Type: Article

References (52)

1. Hong C.H., Kim H.J., Park J.H., et al. Treatment of patients with gastric variceal hemorrhage: Endoscopic N-Butyl-2Cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2009, 24:372-378.
2. Hirota S., Matsumoto S., Tomita M., et al. Retrograde transvenous obliteration of gastric varices. Radiology 1999, 211:349-356.
3. Kitamoto M., Imamura M., Kamada K., et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol 2002, 178:1167-1174.
4. Fukuda T., Hirota S., Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. JVIR J Vasc Interv Radiol 2001, 12:327-336.
5. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter obliteration of gastric varices: Part-1. Anatomic classification. Radiographics 2003, 23:911-920.
6. Kiyosue H., Mori H., Matsumoto S., et al. Transcatheter obliteration of gastric varices: Part-2. Strategy and techniques based on hemodynamic features. Radiographics 2003, 23:921-937.
7. Ibukuro K., Sugihara T., Tanaka R., et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy. JVIR J Vasc Interv Radiol 2007, 18:121-125.
8. Kanagawa H., Mima S., Kouyama H., et al. A successful treated case of fundic varices by retrograde transvenous obliteration with balloon. Nihon Shokakibyo Gakkai Zasshi 1991, 88:1452-1462.
9. Kanagawa H., Mima S., Kouyama H., et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996, 11:51-58.
10. Ninoi T., Nishida N., Kaminou T., et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with Gastro renal shunt: Long-term follow-up in 78 patients. AJR Am J Roentgenol 2005, 184:1340-1346.
11. Akahoshi T., Hashizume M., Tomikawa M., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: A 10-year experience. J Gastroenterol Hepatol 2008, 23:1702-1709.
12. Cho S.K., Shin S.W., Lee I.H., et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: Outcomes and complications in 49 patients. AJR Am J Roentgenol 2007, 189:W365-W372.
13. Ninoi T., Nakamura K., Kaminou T., et al. TIPS versus transcatheter sclerotherapy for gatsric varices. AJR Am J Roentgenol 2004, 183:369-376.
14. Shimoda R., Horiuchi K., Hagiwara S., et al. Short-term complications of balloon-occluded retrograde transvenous obliteration of gastric varices in patients with portal hypertension: Effects of obliteration of major portosystemic shunts. Abdom Imaging 2005, 30:306-313.
15. Park S.J., Chung J.W., Kim H.C., et al. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. JVIR J Vasc Interv Radiol 2010, 21:503-507.
16. Kumamoto M., Toyonaga A., Inoue H., et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol 2010, 25:1129-1135.
17. Chikamori F., Kuniyoshi N., Shibuya S., et al. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery 2001, 129:414-420.
18. Koizumi J., Hashimoto T., Myojin K., et al. C-arm CT-guided foam sclerotherapy for the treatment of gastric varices. J Vasc Interv Radiol 2010, 21:1583-1587.
19. Tanihata H., Minamiguchi H., Sato M., et al. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices. Cardiovasc Intervent Radiol 2009, 32:1209-1216.
20. Choi Y.S., Lee J.H., Sinn D.H., et al. Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices. J Clin Gastroenterol 2008, 42:974-979.
21. Nakamura S., Torii N., Yatsuji S., et al. Long-term follow-up of esophageal varices after balloon-occluded retrograde transvenous obliteration for gastric varices. Hepatol Res 2008, 38:340-347.
22. Yamagami T., Kato T., Hirota T., et al. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration. Australas Radiol 2007, 51:334-338.
23. Sonomura T., Sato M., Kishi K., et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: A feasibility study. Cardiovasc Intervent Radiol 1998, 21:27-30.
24. Chikamori F., Kuniyoshi N., Kawashima T., et al. Gastric varices with gastrorenal shunt: Combined therapy using transjugular retrograde obliteration and partial splenic embolization. AJR Am J Roengenol 2008, 191:555-559.
25. Chikamori F., Kuniyoshi N., Shibuya S., et al. Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy with esophageal varices. Hepatogastroenterology 2004, 51:1379-1381.
26. Miyamoto Y., Oho K., Kumamoto M., et al. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J Gastroenterol Hepatol 2003, 18:934-942.
27. Sugimori K., Morimoto M., Shirato K., et al. Retrograde transvenous obliteration of gastric varices associated with large collateral veins or a large gastrorenal shunt. JVIR J Vasc Intrev Radiol 2005, 16:113-118.
28. Fukuda T., Hirota S., Matsumoto S., et al. Application of balloon-occluded retrograde transvenous obliteration to gastric varices complicating refractory ascites. Cardiovasc Intervent Radiol 2004, 27:64-67.
29. Takuma Y., Nouso K., Makino Y., et al. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol 2005, 3:1245-1252.
30. Arai H., Abe T., Takagi H., et al. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol 2006, 12:3866-3873.
31. Arai H., Abe T., Shimoda R., et al. Emergency balloon-occluded retrograde transvenous obliteration for gastric fundal varices. J Gastroenterol 2005, 40:964-971.
32. Choi Y.H., Yoon C.J., Park J.H., et al. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: Its feasibility compared with transjugular intrahepatic portosystemic shunt (TIPS). Korean J Radiol 2003, 4:109-116.
33. Park K.S., Kim Y.H., Choi J.S., et al. Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding. Korean J Gastroenterol 2006, 47:370-378.
34. Matsumoto A., Hamamoto N., Nomura T., et al. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices. Am J Gastroenterol 1999, 94:643-649.
35. Saad W.E. The history and evolution of balloon-occluded retrograde transvenous obliteration (BRTO): From the United States to Japan and back. Semin Interv Radiol 2011, 28:283-287.
36. Choi S.Y., Won J.Y., Kim K.A., et al. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur Radiol 2011, 21:122-129.
37. Koizumi J., Hashimoto T., Myojin K., et al. C-arm CT-guided foam sclerotherapy for the treatment of gastric varices. J Vasc Interv Radiol 2010, 21:1583-1587.
38. Tanoue S., Kiyosue H., Matsumoto S., et al. Development of a new coaxial balloon catheter system for balloon-occluded retrograde transvenous obliteration (B-RTO). Cardiovasc Intervent Radiol 2006, 29:991-996.
39. Saad W.E., Nicholson D., Lippert A., et al. Balloon rupture during balloon-occluded retrograde tranvenous obliteration (BRTO) of gastric varices utilizing sodium tetradecyl sulfate: incidence and consequences. Vasc Endovasc Surg 2012, in press.
40. Saad W.E., Sabri S.S. Balloon-occluded retrograde transvenous obliteration (BRTO): Technical results and outcomes. Semin Interv Radiol 2011, 28:333-338.
41. Duffy D.M. Sclerosants: A comparative review. Dermatol Surg 2010, 36(suppl 2):1010-1025.
42. Hashizume M., Kitano S., Yamaga H., et al. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Lancet 1988, 2:340-341.
43. Sabri S.S., Saad W.E. Balloon-occluded retrograde transvenous obliteration (BRTO): Technique and intraprocedural imaging. Semin Interv Radiol 2011, 28:283-287.
44. McAree B., Ikonmwosa A., Brockbank K., et al. Comparative stability of sodium tetradecyl sulphate (STD), and polidocanol foam: Impact on vein damage in an in-vitro model. Eur J Vasc Endovasc Surg 2012, 43:721-725.
45. Patel A, Fischman A, Saad WE: Balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices. AJR Am J Roentgenol (in press).
46. Demagny A. Comparative study into the efficacy of a sclerosant product in the form of liquid or foam in echo-guided of arches of the long and short saphenous veins. Phlebologie 2002, 55:133-137.
47. Coleridge Smith P. Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology 2009, 24:260-269.
48. Gandini R., Chiocchi M., Konda D., et al. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. Cardiovasc Intervent Radiol 2008, 31:778-784.
49. Gandini R., Konda D., Reale C.A., et al. Male varicocele: Transcatheter foam sclerotherapy with sodium tetradecyl sulfate-outcome in 244 patients. Radiology 2008, 246:612-618.
50. Tessari L. Nouvelle technique d'obtention de la sclero-mousse. Phlebologie 2000, 53:339-342.
51. Sabri S.S., Swee W., Turba U.C., et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011, 22:309-316.
52. Orsini C., Brotto M. Immediate pathologic effects on the vein wall of foam sclerotherapy. Dermatol Surg 2007, 33:1250-1254.